Harvard |

Harvard

Matches in Harvard for { <http://id.lib.harvard.edu/aleph/008382337/catalog> ?p ?o. }

Showing items 1 to 28 of 28 with 100 items per page.

catalog contributor b11674640.
catalog created "c2000.".
catalog date "2000".
catalog date "c2000.".
catalog dateCopyrighted "c2000.".
catalog description "Ch. 11. P-glycoprotein -- Ch. 12. Other CYP: 2A6, 2B6, 4A -- Ch. 13. UDP-glucuronosyltransferases -- Ch. 14. Glutathione S-tranferases -- Ch. 15. Sulfotransferases and methyltransferases -- Ch. 16. Epoxide hydrolases -- Sect. III. Drugs as substrates of metabolic enzymes treatment of CNS diseases -- Ch. 17. Anticonvulsants -- Ch. 18. Antidepressants -- Ch. 19. Antipsychotics -- Ch. 20. Sedative-hypnotic and anxiolytic agents -- Ch. 21. Volatile, Intravenous, and local anesthetics -- Ch. 22. Opioid analgesics".
catalog description "Ch. 23. Agents for the treatment of migraine, Parkinson's, and Alzheimer's diseases -- Ch. 24. Calcium channel blockers -- Ch. 25. β-adrenoreceptor antagonists -- Ch. 26. Angiotensin II antagonists, ACE inhibitors, and diuretics -- Ch. 27. Cholesterol-lowering agents and cardiac glycosides -- Ch. 28. Antiarrhythmics -- Ch. 29. Oral anticoagulants -- Ch. 30. Oral antifungals -- Ch. 31. Antivirals -- Ch. 32. H₁-receptor antagonists -- Ch. 33. Analgesics-antipyretics -- Ch. 34. Nonsteroidal antiinflammatory drugs -- Ch. 35. Methylxanthines".
catalog description "Ch. 36. H₂-antagonists, proton-pump inhibitors, and antiemetics -- Ch. 37. Immunosuppressive agents -- Ch. 38. Estrogens and progestins -- Ch. 39. Hypoglycemic agents -- Ch. 40. Antineoplastic agents -- Sect. IV. Drugs as inhibitors of metabolic enzymes treatment of CNS diseases -- Ch. 41. Anticonvulsants -- Ch. 42. Antidepressants -- Ch. 43. Neuroleptics and antipsycholtics -- Ch. 44. Calcium channel blockers -- Ch. 45. Antiarrythmics -- Ch. 46. Antimicrobials and antiparasitics -- Ch. 47. Antifungals -- Ch. 48. Protease inhibitors -- Ch. 49. H₂-receptor antagonists".
catalog description "Ch. 50. Inhibitors in the diet: grapefruit juice-drug interactions -- Sect. V. Drugs as inducers of metabolic enzymes -- Ch. 51. Phenobarbital, phenytoin, and carbamazepine -- Ch. 52. Rifampin, dexamethasone, and omeprazole -- Ch. 53. Isoniazid and ethanol -- Sect. VI.: Clinical Considerations -- Ch. 54. Clinical and pharmacoeconomic significance of metabolic drug interactions -- Ch. 55. Pharmacist management of drug interactions -- Ch. 56. Interactions in the elderly -- Sect. VII. Appendix.".
catalog description "Includes bibliographical references and indexes.".
catalog description "Sect. I. Prediction of drug interactions from In Vitro studies: basic principles -- Ch. 1. Metabolically-based drug-drug interactions: principles and mechanisms -- Ch. 2. From In Vitro to In Vivo: an academic perspective -- Ch. 3. Industrial viewpoint: application of In Vitro drug metabolism in various phases of drug development -- Ch. 4. Regulatory viewpoint: prediction of drug interactions from In Vitro studies -- Sect. II. Enzymes and transporters -- Ch. 5. Cytochromes P450: historical overview -- Ch. 6. CYP1A -- Ch. 7. CYP2C -- Ch. 8. CYP2D6 -- Ch. 9. CYP2E1 -- Ch. 10. CYP3A".
catalog extent "xxi, 793 p. :".
catalog identifier "0781714419 (alk. paper)".
catalog issued "2000".
catalog issued "c2000.".
catalog language "eng".
catalog publisher "Philadelphia : Lippincott Williams & Wilkins,".
catalog subject "615.7045 21".
catalog subject "Drug Interactions.".
catalog subject "Metabolism drug effects.".
catalog subject "QV 38 M5873 2000".
catalog tableOfContents "Ch. 11. P-glycoprotein -- Ch. 12. Other CYP: 2A6, 2B6, 4A -- Ch. 13. UDP-glucuronosyltransferases -- Ch. 14. Glutathione S-tranferases -- Ch. 15. Sulfotransferases and methyltransferases -- Ch. 16. Epoxide hydrolases -- Sect. III. Drugs as substrates of metabolic enzymes treatment of CNS diseases -- Ch. 17. Anticonvulsants -- Ch. 18. Antidepressants -- Ch. 19. Antipsychotics -- Ch. 20. Sedative-hypnotic and anxiolytic agents -- Ch. 21. Volatile, Intravenous, and local anesthetics -- Ch. 22. Opioid analgesics".
catalog tableOfContents "Ch. 23. Agents for the treatment of migraine, Parkinson's, and Alzheimer's diseases -- Ch. 24. Calcium channel blockers -- Ch. 25. β-adrenoreceptor antagonists -- Ch. 26. Angiotensin II antagonists, ACE inhibitors, and diuretics -- Ch. 27. Cholesterol-lowering agents and cardiac glycosides -- Ch. 28. Antiarrhythmics -- Ch. 29. Oral anticoagulants -- Ch. 30. Oral antifungals -- Ch. 31. Antivirals -- Ch. 32. H₁-receptor antagonists -- Ch. 33. Analgesics-antipyretics -- Ch. 34. Nonsteroidal antiinflammatory drugs -- Ch. 35. Methylxanthines".
catalog tableOfContents "Ch. 36. H₂-antagonists, proton-pump inhibitors, and antiemetics -- Ch. 37. Immunosuppressive agents -- Ch. 38. Estrogens and progestins -- Ch. 39. Hypoglycemic agents -- Ch. 40. Antineoplastic agents -- Sect. IV. Drugs as inhibitors of metabolic enzymes treatment of CNS diseases -- Ch. 41. Anticonvulsants -- Ch. 42. Antidepressants -- Ch. 43. Neuroleptics and antipsycholtics -- Ch. 44. Calcium channel blockers -- Ch. 45. Antiarrythmics -- Ch. 46. Antimicrobials and antiparasitics -- Ch. 47. Antifungals -- Ch. 48. Protease inhibitors -- Ch. 49. H₂-receptor antagonists".
catalog tableOfContents "Ch. 50. Inhibitors in the diet: grapefruit juice-drug interactions -- Sect. V. Drugs as inducers of metabolic enzymes -- Ch. 51. Phenobarbital, phenytoin, and carbamazepine -- Ch. 52. Rifampin, dexamethasone, and omeprazole -- Ch. 53. Isoniazid and ethanol -- Sect. VI.: Clinical Considerations -- Ch. 54. Clinical and pharmacoeconomic significance of metabolic drug interactions -- Ch. 55. Pharmacist management of drug interactions -- Ch. 56. Interactions in the elderly -- Sect. VII. Appendix.".
catalog tableOfContents "Sect. I. Prediction of drug interactions from In Vitro studies: basic principles -- Ch. 1. Metabolically-based drug-drug interactions: principles and mechanisms -- Ch. 2. From In Vitro to In Vivo: an academic perspective -- Ch. 3. Industrial viewpoint: application of In Vitro drug metabolism in various phases of drug development -- Ch. 4. Regulatory viewpoint: prediction of drug interactions from In Vitro studies -- Sect. II. Enzymes and transporters -- Ch. 5. Cytochromes P450: historical overview -- Ch. 6. CYP1A -- Ch. 7. CYP2C -- Ch. 8. CYP2D6 -- Ch. 9. CYP2E1 -- Ch. 10. CYP3A".
catalog title "Metabolic drug interactions / René H. Levy ... [et al.].".
catalog type "text".